Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark K Meiselbach

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Medical Care|March 14, 2023
Measurement Approaches to Estimating Methadone Continuity in Opioid Use Disorder CareAlisa B Busch, Alene Kennedy-Hendricks, Cameron Schilling, et al.
Journal of Managed Care & Specialty Pharmacy|May 26, 2018
Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims DataNicholas J Vogelzang, Sumanta K Pal, Sameer R Ghate, et al.
Advances in Therapy|October 28, 2017
Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims AnalysisNicholas J Vogelzang, Sumanta K Pal, Sameer R Ghate, et al.
Drug and Alcohol Dependence|November 12, 2022
High deductible health plans and spending among families with a substance use disorderMark K Meiselbach, Alene Kennedy-Hendricks, Cameron Schilling, et al.
Journal of the American Geriatrics Society|April 3, 2018
One-Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort StudyNicole R Fowler, Noll L Campbell, Gerhardt M Pohl, et al.
American Journal of Preventive Medicine|May 15, 2023
Impact of High Deductible Health Plans on U.S. Adults With Chronic PainAlene Kennedy-Hendricks, Julia C P Eddelbuettel, Mark C Bicket, et al.
Journal of Substance Use and Addiction Treatment|September 2, 2023
Choice of high-deductible health plans among enrollees with a substance use disorderMark K Meiselbach, Haiden A Huskamp, Julia C P Eddelbuettel, et al.
Medical Care|July 14, 2023
High-deductible Health Plans and Nonfatal Opioid OverdoseJulia C P Eddelbuettel, Colleen L Barry, Alene Kennedy-Hendricks, et al.
Journal of General Internal Medicine|March 8, 2024
Changes in Healthcare Spending Attributable to High Deductible Health Plan Offer Among Enrollees with Comorbid Substance Use Disorder and Cardiovascular DiseaseJulia C P Eddelbuettel, Alene Kennedy-Hendricks, Mark K Meiselbach, et al.
Medical Care Research and Review : MCRR|June 22, 2023
Do High-Deductible Health Plans Incentivize Changing the Timing of Substance Use Disorder Treatment?Mara A G Hollander, Alene Kennedy-Hendricks, Cameron Schilling, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Medical Care|March 14, 2023
Measurement Approaches to Estimating Methadone Continuity in Opioid Use Disorder CareAlisa B Busch, Alene Kennedy-Hendricks, Cameron Schilling, et al.
Journal of Managed Care & Specialty Pharmacy|May 26, 2018
Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims DataNicholas J Vogelzang, Sumanta K Pal, Sameer R Ghate, et al.
Advances in Therapy|October 28, 2017
Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims AnalysisNicholas J Vogelzang, Sumanta K Pal, Sameer R Ghate, et al.
Drug and Alcohol Dependence|November 12, 2022
High deductible health plans and spending among families with a substance use disorderMark K Meiselbach, Alene Kennedy-Hendricks, Cameron Schilling, et al.
Journal of the American Geriatrics Society|April 3, 2018
One-Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort StudyNicole R Fowler, Noll L Campbell, Gerhardt M Pohl, et al.
American Journal of Preventive Medicine|May 15, 2023
Impact of High Deductible Health Plans on U.S. Adults With Chronic PainAlene Kennedy-Hendricks, Julia C P Eddelbuettel, Mark C Bicket, et al.
Journal of Substance Use and Addiction Treatment|September 2, 2023
Choice of high-deductible health plans among enrollees with a substance use disorderMark K Meiselbach, Haiden A Huskamp, Julia C P Eddelbuettel, et al.
Medical Care|July 14, 2023
High-deductible Health Plans and Nonfatal Opioid OverdoseJulia C P Eddelbuettel, Colleen L Barry, Alene Kennedy-Hendricks, et al.
Journal of General Internal Medicine|March 8, 2024
Changes in Healthcare Spending Attributable to High Deductible Health Plan Offer Among Enrollees with Comorbid Substance Use Disorder and Cardiovascular DiseaseJulia C P Eddelbuettel, Alene Kennedy-Hendricks, Mark K Meiselbach, et al.
Medical Care Research and Review : MCRR|June 22, 2023
Do High-Deductible Health Plans Incentivize Changing the Timing of Substance Use Disorder Treatment?Mara A G Hollander, Alene Kennedy-Hendricks, Cameron Schilling, et al.
Pageof 5